Item

13-year-old in Pfizer Covid vaccine trial who wants to be an epidemiologist: ‘I like to learn everything I can

Title (Dublin Core)

13-year-old in Pfizer Covid vaccine trial who wants to be an epidemiologist: ‘I like to learn everything I can

Description (Dublin Core)

Recently CNBC has released an article on my story in the Pfizer Vaccine Trial. I got interviewed about a week ago, and I helped in the making of the article. It is on a division of CNBC called CNBC Make It. CNBC Make It is a section of CNBC that specializes in money, wellness, and heartwarming stories. I have gotten to know the writer, Cory Stieg, well and it was great working with her. The article goes into detail about how the trial works and my experience with the trial. This experience has been amazing from both ends, Pfizer and CNBC. I hope that I inspired others to make a change in the world and to try and pursue your passions.

Link to Article in Description

Date (Dublin Core)

April 17, 2021

Creator (Dublin Core)

Cory Steig

Contributor (Dublin Core)

Andrew Brandt

Type (Dublin Core)

Article

Link (Bibliographic Ontology)

Controlled Vocabulary (Dublin Core)

English Health & Wellness
English Public Health & Hospitals
English Home & Family Life
English Education--K12

Curator's Tags (Omeka Classic)

vaccine
Pfizer vaccine
trial
epidemiology
parent
grandparent
Ochsner Medical Center
New Orleans
double-blind trial
Youtube
high school

Contributor's Tags (a true folksonomy) (Friend of a Friend)

COVID-19
Vaccine
Trial
Help

Collection (Dublin Core)

Healthcare
Children
Vaccine Stories

Date Submitted (Dublin Core)

05/19/2021

Date Modified (Dublin Core)

05/26/2021
10/06/2021
04/18/2022

Date Created (Dublin Core)

04/17/2021

Item sets

This item was submitted on May 19, 2021 by Andrew Brandt using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA